SRRA

Sierra Oncology, Inc. Common Stock
SRRA

Overview Fund Activity
Delisted

SRRA was delisted on the 30th of June, 2022.

Back to rankings

42 hedge funds and large institutions have $18.7M invested in Sierra Oncology, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
-2
Holders Change %
-4.55%
% of All Funds
1.12%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
8
Increased
12
Reduced
9
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BCM
1
Bridgeway Capital Management
Texas
$610K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$411K
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$294K
4
Deutsche Bank
4
Deutsche Bank
Germany
$309K
5
PNC Financial Services Group
5
PNC Financial Services Group
Pennsylvania
$1.29M

Top Sellers

1
PAMU
1
Pictet Asset Management (UK)
United Kingdom
$0
2
ASP
2
Adams Street Partners
Illinois
$0
3
DM
3
Deerfield Management
New York
$2.53M
4
QF
4
QVT Financial
New York
$0
5
AA
5
Ancora Advisors
Ohio
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PMFA
51
Plante Moran Financial Advisors
Michigan
– -$8K -106 Closed
UBS Group
52
UBS Group
Switzerland
– -$8K -104 Closed
1 2
3